Silo Pharma, Inc. (SILO)
2025-06-30 | ||||
|---|---|---|---|---|
| Unrealized gain (loss) on short-term debt investments | -1,140 | |||
| Provision for income taxes | - | |||
| Loss before provision for income taxes | -1,204,293 | |||
| Net loss | -1,204,293 | |||
| Total comprehensive loss | -1,205,433 | |||
| Basic (in dollars per share) | -0.19 | |||
| Basic (in shares) | 6,279,733 | |||
| Diluted (in dollars per share) | -0.19 | |||
| Diluted (in shares) | 6,279,733 | |||